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Abstract

Epidemiologic studies reveal that women have a significantly lower age-adjusted morbidity and mortality from
cardiovascular disease than men, suggesting that gender is a cardiovascular disease risk factor. The mechanism

of the “gender protection” is unknown. In this study, we investigated the microvascular remodeling in reduced
renal mass plus a high salt (4.0% NaCl) diet model of hypertension (RRM + HS). We hypothesized that women
would be protected from the increase in blood pressure and from the microvascular rarefaction associated with
RRM + HS hypertension. Studies were designed to determine whether female rats were less susceptible to
changes in microvessel density during RRM + HS. Microvessel density was measured in male and female low salt
(0.4% LS) sham-operated controls (Sham + LS) and after 3 days or 4 weeks of RRM + HS hypertension. The
microcirculation of hind limb (medial and lateral gastrocnemius, plantaris, soleus) muscles was visualized using
rhodamine-labeled Griffonia simplicifolia I lectin. Tissue sections were examined by videomicroscopy and
microvessel density was determined by quantitative stereology. As shown previously, mean arterial pressure
increased to 160 ± 8 mm Hg and microvessel density decreased (>30% decrease in all beds) in male RRM + HS. In
contrast, mean arterial pressure of female RRM + HS rats was modestly increased from 101 ± 2 to 118 ± 4 mm
Hg. Despite previous results showing a reduction in microvessel density of both normotensive and hypertensive
male rats on a high salt diet, microvessel density of female RRM + HS rats was not reduced at either time. These
results suggest that gender protection in the RRM rat extends beyond an attenuation of the increase in pressure
to an immunity from microvascular rarefaction.
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Epidemiologic studies, most notably the Framingham studies1 have described a greater age-adjusted mortality
and morbidity from cardiovascular disease in men when compared to women. On the basis of these and other
epidemiologic studies, gender (ie, being male) is identified as a risk factor for developing cardiovascular
disease.2 A similar age-adjusted sexual dimorphism exists with regard to the prevalence of hypertension.3The
prevalence of hypertension is greater in men of all ages when compared to women. This gender difference exists
until women reach or exceed 50 years of age, and coincides with the “postmenopausal” years when plasma
estrogen and progesterone levels are decreased. Furthermore, postmenopausal women who receive hormone
replacement therapy (ie, estrogen) have a 30% to 50% decrease in cardiovascular mortality and a 50% reduction
in cerebrovascular mortality rate when compared to untreated women.4
A sexual dimorphism also exists in a variety of animal models of hypertension, including both genetic5,6 and
experimental models.7,–9 Although these differences have been the focus of several investigations, they remain
unexplained. To date these gender differences cannot be fully explained by changes in other known
cardiovascular disease risk factors, for example, plasma lipid levels,10 by changes in plasma vasopressin
concentrations,11 or changes in peripheral vascular receptor sensitivity.12
One of the most striking morphologic changes associated with many forms of hypertension is a remodeling of
the microcirculation. This remodeling includes both a reduction in vessel density (microvessel rarefaction) and
histologic changes. Decreases in microvessel density (arterioles and capillaries), as well as degenerative changes
that include vascular smooth muscle cell atrophy and attenuation of the endothelium, have been well described
by a number of investigators.13,,,,,,,,,–23 For example, in the reduced renal mass plus a high sodium intake (RRM +
HS) model of hypertension, the elevated arterial pressure is accompanied by a 10% to 30% anatomic rarefaction
of the microcirculation in skeletal muscle.16,17 The association of an increase in mean arterial pressure (MAP) and
a loss of microvessel density is not unique to the RRM model or to animal models alone. Rather, microvessel
rarefaction occurs in many different animal models of hypertension, including the SHR,14,18,20,24 2 kidney-1clip,19 and DOCA-salt22hypertension. Rarefaction has also been demonstrated in patients with essential
hypertension.25 However, all studies of remodeling of the microcirculation in hypertension to date have been

confined to men. Because it is now well established that premenopausal women exhibit an apparent resistance
to the development of hypertension, a finding supported by animal models, we hypothesized that the gender
protection in terms of elevated pressure in female RRM + HS rats would extend to protection of the
microcirculation from rarefaction.

Materials and Methods
All protocols and procedures were approved by the Institutional Animal Care and Use Committee at the Medical
College of Wisconsin. Male and female Sprague-Dawley rats (Sasco, Madison, WI) arrived 7 to 10 days before
the date of surgery to permit adaptation to their new environment. All animals were fed a low sodium diet
(0.4% NaCl, AIN-76A, Dyets Inc., Bethelem, PA) and water ad lib.

Surgical Procedure
A reduction in renal mass (RRM) of approximately 75% was achieved using a two-stage surgical procedure as
previously described.17,26 All surgeries were performed with intramuscular ketamine (100 mg/kg) and
acepromazine anesthesia (1 mg/kg) using sterile techniques. Briefly, the right kidney was exposed by a flank
incision and the two poles removed. After a 2-week recovery period, the entire left kidney was removed. Shamoperated (Sham) control rats were handled similarly, the kidneys exposed, cleared of perirenal fat, and returned
to the abdominal cavity. All rats were kept on a low salt diet for an additional week after the second surgery.
Animals were randomly divided into experimental groups. In the first group, male and female Sham + LS (low
salt 0.4%) and RRM + HS (high salt 4.0%) rats were fed high or low salt diets (AIN-76A, Dyets Inc.) for 3 days. A
total of 29 animals were used. In the second group, male and female Sham + LS and RRM + HS were fed high or
low salt diets for 4 weeks. A total of 32 animals were used. In a third group, male (n = 14) and female (n = 5)
RRM + HS were fed high salt diets for 4 weeks.

Surgical Implantation of Catheters and Acute Arterial Pressure
Measurements
Rats were lightly anesthetized with a combination of intraperitoneal sodium pentobarbital (15 mg/kg) and
ketamine (50 mg/kg). Catheters (microbore Tygon and Dural tubing) were surgically implanted into the femoral
arteries of rats, as previously described.27 The catheter was flushed, filled with diluted heparin in saline and
connected to a COBE pressure transducer (Arvada, CO). Direct arterial pressures were recorded continuously for
30 to 60 min as previously described.26 The arterial pressure signal from the transducer was digitized and the
data stored for later analysis. Mean arterial pressure was analyzed using data acquisition software (CODAS,
Dataq Instruments Inc., Akron, OH; sampling rate of 60 Hz) and stored as minute averages. A single mean ± SE
was calculated for MAP for each individual animal. The animal was then euthanized with an overdose of sodium
pentobarbital.

Surgical Implantation of Catheters and Chronic Arterial Pressure
Measurements
To eliminate any difference in depth or response to anesthesia in the measurement of blood pressure, male and
female RRM + HS rats (n = 19) were surgically prepared with chronic indwelling catheters as previously described
in detail.27 Briefly, specially designed catheters (microbore Tygon and Dural tubing) were surgically implanted
into the femoral arteries of anesthetized rats (ketamine, 100 mg/kg and intramuscular acepromazine, 1 mg/kg)
using sterile techniques. The catheter was tunneled subcutaneously to exit in the subscapular region and
protected by a light weight spring. The spring and catheter were connected to a swivel mounted on top of the
cage. Rats were given 3 to 5 days of recovery. Morning pressures were measured after the catheter was flushed,

filled with diluted heparin in saline, and connected to a COBE pressure transducer (Arvada). All animals
remained in their home cages and were untouched during the procedure. Pressures were recorded for 1 h and a
single mean calculated for each animal as described above. Because of the potential influence of the indwelling
chronic cannula on distal extremity blood flow, vessel density was not determined in these animals.

Vessel Density Determination
Microvessel density was determined using Griffonia simplicifolia I lectin, a probe specific for vessels of the
microcirculation with high-affinity binding to vessels of diameters 20 μm or less.17 The gastrocnemius-plantarissoleus muscles were removed and rinsed in physiologic salt solution (PSS). The tissue was immediately sectioned
using a microtome.28 The two 75-μm thick longitudinal sections were immersed in 25 μg/mL rhodaminelabeled Griffonia simplicifolia I (GS-I) lectin (Sigma Chemical Corp., St. Louis, MO) for 45 min to define the
microvascular bed. After immersion, the tissue was rinsed in PSS three times and the sample was mounted on a
microscope slide with a water-soluble mountant (Cytoseal 280, Stephens Scientific, Riverdale, NJ). Labeled
sections were visualized using a video fluorescent microscope system (Olympus ULWD CD Plan, 20× objective,
1.6 working distance, and 0.4 numerical aperture, Lake Success, NY) with epiillumination. Images were obtained
using a single-stage intensified Newvicon camera (model 7010, Olympus, Cohu, California) with 12
representative images from each tissue used for quantifying vessel density. Each image was digitized and
processed to determine microvessel density as we have previously described elsewhere.29

Statistical analysis
Data are presented as mean ± standard error. The vessel density estimates determined from each of the 12
different images obtained from each tissue were averaged to represent the vessel density for a single animal.
Vessel density estimates of each individual animal were then used to compute group data. Group MAP was
determined using the average of the 1-h recording. One-way or two-way analysis of variance were used to
determine significant effects. Differences in cell means were determined by a Duncan’s multiple range test
(significance, P < .05).

Results
The descriptive data of all experimental groups is shown in Table 1. Sham + LS males had a small but significantly
lower initial (presurgical) body weight and were 9 days younger than rats in the RRM + HS group. Final body
weights of male rats were significantly greater than females in all groups, and in both experiments. There were
no other significant differences between groups. The percent of renal mass remaining calculated after surgical
reduction was not significantly different between male and females in either the 3-day or 4-week studies.
Table 1. Age, body weight (initial and final), and percent of renal mass remaining after surgical reduction in
preparation of the reduced renal mass (RRM) + high salt diet model of hypertension in rats

Group one: Effect of 3 days of
diet
Male
RRM + HS
SHAM + LS
Female

Age
(days)

N

Body Weight
(g)
Initial

85 ± 1*
76 ± 2

13
6

239 ± 14†
198 ± 2

Final

% Renal Mass
Remaining

396 ± 8†
366 ± 6†

27 ± 2
NA

RRM + HS
SHAM + LS
Group two: Effect of 4 weeks of
diet
Male
RRM + HS

85 ± 1
81 ± 2

6
7

194 ± 3
200 ± 1

250 ± 5
278 ± 6

28 ± 1
NA

111 ± 4

13

219 ± 9

25 ± 5

SHAM + LS

109 ± 4

7

215 ± 7

460 ±
10†
476 ±
12†

Female
RRM + HS
107 ± 1
6
207 ± 3
272 ± 5
SHAM + LS
107 ± 1
6
199 ± 1
297 ± 8
Data are presented as mean ± 1 SE.
*Significantly greater than male sham-operated, low salt control, P < .05.
†Significantly greater than matched female group, P < .05.

NA

22 ± 1
NA

A 75% reduction of renal mass in combination with 4 weeks of a high salt intake resulted in a significant increase
in MAP in both male and female RRM + HS rats as summarized in Figure 1. However, in males, the increase in
arterial pressure was more rapid, that is, MAP was significantly increased after 3 days of high salt (134 ± 6 mm
Hg) when compared to sham-operated, low salt control (103 ± 3 mm Hg). Arterial pressure was further
increased after 4 weeks of high salt in males (134 ± 6 to 160 ± 8 mm Hg). In contrast, arterial pressure of female
RRM + HS rats was not significantly different than controls at 3 days. Arterial pressure of female RRM-HS rats
increased significantly from 111 ± 3 after 3 days to 118 ± 4 mm Hg after 4 weeks of high salt intake. At both 3
days and 4 weeks, arterial pressure of male RRM + HS rats was significantly greater than that of female RRM +
HS. There was no significant difference in the MAPs obtained using the acute and chronic techniques (Table 2).
There were no differences using these two techniques for either male or female rats.
Mean arterial pressure (MAP) measured in anesthetized male and female reduced renal mass + high salt (RRM
+ HS) and sham-operated + low salt controls (SHAM + LS) after either 3 days or 4 weeks of diet. MAP was
significantly increased in male RRM + HS rats at 3 days, and was further increased at 4 weeks when compared
to SHAM + LS. MAP was significantly greater in male RRM + HS when compared to females. #Significantly
different from female RRM + HS, P < .05. *Significantly different from same gender SHAM + LS control, P < .05.
Figure 1.

Table 2. Mean arterial pressure in conscious and anesthetized male and female reduce renal mass (RRM) + high
salt rats after 4 weeks of high salt diet
Group Three
Conscious N
Anesthetized N
Male
RRM + HS
152 ± 5*
14 160 ± 8*
6
Female (nonestrous)
RRM + HS
121 ± 2
5
118 ± 4
8
Values are mean ± SEM.
*Indicates significant difference from female under same condition, P < .05.
The influence of gender on the microvasculature is evidenced by significant changes in microvessel density in
male but not in female rats. Vessel density was significantly reduced in the gastrocnemius-white muscle in male
RRM + HS rats after 3 days of high salt when compared to male Sham + LS (Figure 2). Vessel density of the
gastrocnemius-white muscle was significantly lower in male RRM rats when compared to females. There were
no significant differences in the vessel density of any of the skeletal muscles of female RRM + HS. There were no
significant differences in the vessel density of any of the skeletal muscles in male and female sham-operated
animals.
As shown in Figure 3, vessel density was significantly decreased in all hind limb muscles measured in male RRM
+ HS rats after 4 weeks of high salt when compared to male Sham + LS controls. In contrast, no significant
changes in vessel density were observed in female RRM + HS rats. In addition, vessel density was significantly
lower in all hind limb muscles of male RRM + HS rats when compared to female RRM + HS after 4 weeks.
Vessel density in hind limb muscles of male and female reduced renal mass + high salt (RRM + HS) and shamoperated + low salt controls (SHAM + LS) after 3 days of diets. Vessel density was significantly reduced in
gastrocnemius-white muscle of male RRM + HS rats when compared to female RRM + HS rats. Vessel density
in male RRM + HS rats was significantly lower than in male SHAM + LS controls. #Significantly different from
female RRM + HS, P < .05. *Significantly different from same gender SHAM + LS control, P < .05.

Figure 2.

Microvessel density in male and female reduced renal mass + high salt (RRM + HS) and sham-operated + low
salt controls (SHAM + LS after 4 weeks of diets. Vessel density was significantly reduced in gastrocnemiuswhite, gastrocnemius-red, soleus, and plantaris muscles of male RRM + HS rats compared to female RRM + HS
rats. Vessel density was also significantly lower in male RRM + HS rats than in male SHAM + LS controls.
#Significantly different from female RRM + HS, P < .05. *Significantly different from same gender SHAM + LS
control, P < .05.
Figure 3.

Discussion
This study is the first to demonstrate that female RRM hypertensive rats are protected from microvascular
rarefaction, and have a markedly attenuated increase in MAP. This moderate change in pressure is in contrast to
the rapid and significant elevation in arterial pressure and the microvascular rarefaction seen at an equivalent
time in hypertensive male RRM + HS rats. Our results also confirm the presence of rarefaction in the postural
hind limb muscles of male rats and further demonstrate the progressive loss of microvessels with time in this
experimental model.
In the present study, MAP of male RRM rats was significantly increased after 3 days of high salt diet and was
further increased after 4 weeks. These results are similar to and confirm those previously reported by our
group.16,17,26 However, in female RRM-HS rats, both the magnitude and the time of onset of the pressure
increase was significantly less than in male rats. After 3 days on a high salt diet, MAP of female rats increased to
111 ± 3 mm Hg and this increase was not significantly higher than controls. When fed a high salt diet for 4
weeks, MAP in the female rats increased further. Despite a statistically significant increase in MAP in the female
RRM + HS rats after 4 weeks on a high salt diet, the increase was only modest (118 ± 5 mm Hg). In contrast, MAP
of male RRM + HS rats increased rapidly to 132 ± 6 mm Hg after only 3 days of high salt and was further
increased to 160 ± 7 mm Hg at 4 weeks. The large differences in both the rate of increase of arterial pressure
and in the magnitude of the pressure changes occurred despite the fact that both groups were fed the same
high salt diet and that the percent reduction in renal mass was identical for male and female rats. This effect
cannot be explained by differing responses to anesthesia. In our study, acute pressure measurements were not
significantly different from measurements made in the conscious state (Table 2). This suggests that gender
differences in MAP were not attributable to differences in measurement methods. Gender differences in MAP,
such as those we observed, have been reported in the spontaneously hypertensive rats5,6 and in the DOCA-salt
model of hypertension.7,–9,30
In addition to a significant effect of gender on arterial pressure, gender appeared to modulate the changes in
microvessel density. Microcirculatory beds from skeletal muscle of male rats demonstrated rarefaction, as
evidenced by a significant loss of microvessels from the gastrocnemius-white muscle after only 3 days of high
salt diet. The magnitude of rarefaction seen is identical to that previously reported.29 In contrast, rarefaction did
not occur in female rats (ie, no changes in vessel density were detectable). High salt diet for 4 weeks resulted in
a greater differentiation between male and female rats. In male RRM + HS rats, vessel density was significantly
decreased in all of the hind limb muscles: red and white gastrocnemius, plantaris, and soleus muscles. This was
not the case in female rats, where no significant changes in microvessel density were seen after 4 weeks on a
high salt diet.
In the present studies, differences in vessel density were paralleled by similar gender-related protection from
elevations of MAP. In a previous study, we used a mathematical model to predict the increase in microvascular
resistance caused by rarefaction.16 Using that model, approximately one-third to one-half of the increase in
pressure seen in male RRM + HS hypertensive rats may have been attributable to an uncompensated increase in
microvascular resistance due to rarefaction. Therefore, the absence of rarefaction and the associated increase in
microvascular resistance in the female rats may account, at least in part, for the attenuated arterial pressure
increase seen in the female rats in the present study.
The mechanisms of the gender differences in arterial pressure and rarefaction in the RRM + HS model are
unclear. One explanation could be that female rats did not rarify because arterial pressure changes were
nonexistent or small. That is, that changes in arterial pressure drive the microvessel rarefaction rather than vice

versa. We have previously reported a 20% to 25% reduction in microvessel density of the cremaster muscle of
normal male rats in response to 3 days of a high salt intake, demonstrating that, in male rats, an increase in salt
intake alone induced microvessel rarefaction that was independent of an increase or change in arterial
pressure.31 Boegehold et al13 have also demonstrated a pressure-independent rarefaction in male rats.
Collectively, these results suggest that the absence of rarefaction in female RRM + HS rats is more than just a
manifestation of an attenuated arterial pressure response. Furthermore, the data strongly suggest that
rarefaction is not secondary to an increase in blood pressure in either male or female rats. In fact, we have
recently reported that there are many instances in which microvessel density is either decreased or increased
with no change in blood pressure29,32 Thus, microvessel density is poorly correlated with arterial pressure in an
intact animal model in which compensatory mechanisms are available to buffer such changes.
Variations in the sensitivity to a high salt intake remains as one possible explanation for the differential
responses in arterial pressure and rarefaction. Recently, Calhoun et al6reported that nighttime blood pressures
of male but not female Wistar-Kyoto (WKY) rats increase in response to high salt intake. Furthermore, gender
differences have been reported in all of the models of hypertension that are salt-dependent, DOCA-salt,7,–
9,30
partial nephrectomy salt,33 and salt-sensitive spontaneously hypertensive rat.5,6 These results suggest that the
gender-mediated differences in hypertension and microvessel remodeling may involve the handling of a sodium
load. One possible explanation for the present results could be that male rats consume more salt than did
female rats. Although we did not measure intakes in this present study, Fregly and colleagues34,35have failed to
demonstrate a gender difference in either daily salt intake or salt appetite in DOCA-salt rats. Although male rats
consumed more salt on a per gram basis, these differences disappeared when intake was expressed or adjusted
for the differences in body weight between genders. A second potential mechanism for a salt effect would be
whether there was a difference in the remaining renal mass after surgical reduction. Thus, salt per gram of
kidney weight may be important. In this study, we documented the percentage of renal mass remaining in all
groups (Table 1). There were no significant differences between male and female rats. This suggests that neither
renal mass nor daily salt intake can explain the gender differences found in the present study. However, it does
not eliminate the possibility of a gonadal steroid modulation of a undetermined salt-dependent mechanism.
The renin-angiotensin system is an important regulator of fluid and electrolyte homeostasis that responds to
changes in sodium intake. Angiotensin has also been shown to induce angiogenesis in vitro and in vivo.36,37 A
number of studies from our group and others have demonstrated that vessel density is highly correlated with
plasma angiotensin II levels.28,31,32,37,38 This is in contrast to a poor relationship between arterial pressure and
vessel density. We have demonstrated that the renin-angiotensin system is suppressed and that microvessel
density is reduced in normal male rats placed on a high salt diet (4.0%).28 We have also shown that chronic
infusions of angiotensin II at subpressor doses effectively blocked the rarefaction associated with a high salt
intake25 and, in fact, stimulated angiogenesis in a dose-dependent manner. In addition, Wang and Prewitt39 have
shown that administration of oral captopril (an angiotensin converting enzyme inhibitor) suppresses angiotensin
levels and results in microvessel rarefaction. Similarly, we recently reported that captopril eliminated the normal
angiogenic response to exercise.40 Collectively, these results suggest that the renin-angiotensin system, or more
specifically, angiotensin II affects both angiogenesis and rarefaction. Therefore, it is possible that the reninangiotensin system of female rats responds differently to salt than that of male rats. These possibilities remain
to be investigated.
Finally, it is possible that the gonadal steroids (estrogen, progesterone, or testosterone) have either a direct
effect or act indirectly to modulate arterial pressure and microvessel growth. This is supported by studies of
Crofton et al in which ovariectomy increased systolic blood pressure in rats.7,30 Furthermore, our preliminary
data in ovariectomized DOCA-salt rats with or without estrogen replacement therapy indicated that, without
estrogen, female rats exhibit “male-like” increases in arterial pressure.38 Recently, Crofton and Share30 reported

an attenuation of hypertension in intact male DOCA-salt rats treated with 17-β-estradiol and an exacerbation of
hypertension in gonadectomized male rats. In these studies, ovariectomy resulted in hypertension in female rats
that was essentially blocked by treatment with estradiol. The mechanisms for these gonadal steroid effects
remain undetermined. However, there are many interesting possibilities.
Receptors for estrogen have been found on vascular smooth muscle cells41 and gender differences in an
endothelium-dependent contractile response of isolated aortas have been reported.12 Although the physiologic
function of these receptors is as yet undetermined, their presence supports the concept of a direct effect of
estrogen on the vasculature.42 This hypothesis is supported by the inhibition of angiogenesis in chick egg
chorioallantoic membrane when antiestrogens are administered.43 Possibly, the gonadal steroids act by way of a
modulation of renin angiotensin system or within the central nervous system to modulate arterial pressure.
Androgen receptors have been demonstrated in the cardiovascular blood pressure centers located in the
brainstem25and in the areas responsible for vasopressin release.44 Additional studies are required to understand
the interactions between the gonadal steroids and the mediators of angiogenesis and the long-term controllers
of arterial pressure.
This is the first study to examine the effect of gender on microvascular remodeling. The results suggest that
female rats are protected from salt-induced rarefaction of microvessels and that this lack of rarefaction may
have contributed to the attenuated increase in arterial pressure seen in female rats in this model of
hypertension. Further studies are required to determine the exact mechanism of the protection and to
determine whether estrogen and progesterone are independent modulators of microvessel growth, or whether
they act through the well-known renin-angiotensin system.
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